Starfire Investment Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Starfire Investment Advisers’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$875K	Hold	16,543	–	–	0.42%	63
2020 Q1	$782K	Hold	16,543	–	–	0.43%	60
2019 Q4	$999K	Hold	16,543	–	–	0.38%	61
2019 Q3	$991K	Hold	16,543	–	–	0.41%	61
2019 Q2	$1.06M	Hold	16,543	–	–	0.48%	51
2019 Q1	$1.34M	Hold	16,543	–	–	0.62%	43
2018 Q4	$894K	Buy	16,543 +543	+3%	+$27.7K	0.48%	50
2018 Q3	$825K	Sell	16,000 -543	-3%	-$25.5K	0.41%	55
2018 Q2	$689K	Hold	16,543	–	–	0.35%	66
2018 Q1	$729K	Buy	+16,543	New	+$840K	0.38%	64
2017 Q4	–	Sell	-16,543	Closed	-$838K	–	186
2017 Q3	$838K	Hold	16,543	–	–	0.51%	45
2017 Q2	$841K	Hold	16,543	–	–	0.49%	48
2017 Q1	$651K	Hold	16,543	–	–	0.35%	59
2016 Q4	$791K	Hold	16,543	–	–	0.45%	51
2016 Q3	$606K	Hold	16,543	–	–	0.36%	60
2016 Q2	$385K	Hold	16,543	–	–	0.27%	78
2016 Q1	$670K	Hold	16,543	–	–	0.44%	50
2015 Q4	$1.02M	Hold	16,543	–	–	0.7%	38
2015 Q3	$669K	Hold	16,543	–	–	0.49%	49
2015 Q2	$952K	Hold	16,543	–	–	0.63%	41
2015 Q1	$1.05M	Buy	+16,543	New	+$1.12M	0.69%	36

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Starfire Investment Advisers's IONS Position: Q2 2020 in Review

Starfire Investment Advisers held its Ionis Pharmaceuticals (IONS) position steady in Q2 2020 at 16,543 shares worth $875K. The position accounts for 0.42% of the portfolio, ranked #63.

Starfire Investment Advisers first reported a position in IONS in Q1 2015 and has held it in 21 quarters since. The position peaked at $1.34M in Q1 2019. 375 funds tracked by Wall St. Rank hold IONS as of Q2 2020.

Starfire Investment Advisers held 16,543 shares of Ionis Pharmaceuticals worth $875K as of Q2 2020.
Starfire Investment Advisers left its Ionis Pharmaceuticals share count unchanged in Q2 2020.
Ionis Pharmaceuticals made up 0.42% of Starfire Investment Advisers's portfolio in Q2 2020, its #63 holding.
Starfire Investment Advisers first reported a position in Ionis Pharmaceuticals in Q1 2015 and has held it in 21 quarters since.
Starfire Investment Advisers's Ionis Pharmaceuticals position peaked at $1.34M in Q1 2019.
375 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2020.

Based on Starfire Investment Advisers's 13F filing for Q2 2020, filed 9 Jul 2020.